Protagonist Therapeutics, Inc ($PTGX)
Filing Information
| Accession Number | 0001104659-26-106831 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
375,000
Total Value
$20,938,067.82
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 8, 2026 | Exercise/Conversion | 54,174 | $21.58 | $1,169,074.92 | 577,142 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sale | 54,174 | $145.87 | $7,902,361.38 | 522,968 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Exercise/Conversion | 63,548 | $21.58 | $1,371,365.84 | 586,516 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Sale | 63,548 | $146.18 | $9,289,446.64 | 522,968 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Exercise/Conversion | 7,278 | $21.58 | $157,059.24 | 530,246 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Sale | 7,278 | $144.10 | $1,048,759.80 | 522,968 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 8, 2026 | Exercise/Conversion | 54,174 | $0.00 | $0.00 | 70,826 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 9, 2026 | Exercise/Conversion | 63,548 | $0.00 | $0.00 | 7,278 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 10, 2026 | Exercise/Conversion | 7,278 | $0.00 | $0.00 | 0 | Direct | โ | View Details |